Douglas Hamilton

Mr. Hamilton is a Co-Founder and the Chief Executive Officer of i3 Pharmaceuticals, LLC and Pontis Pharma, LLC. Previously, in 2004, he Co-Founded and held the position of President at Synerx Pharma, LLC, a specialty generic pharmaceutical company which was sold to Mylan Laboratories in 2011. Over his 35+ year career, he has held senior executive positions in Sourcing, New Product Development/Commercialization, Manufacturing, and Business Development at leading pharmaceutical companies including Lederle Labs (now Pfizer), Bristol Myers Squibb, Novartis/Sandoz, and Sanofi-Aventis. Mr. Hamilton holds a B.S. degree in Chemical Engineering from the New Jersey Institute of Technology, as well as an M.B.A. from Fairleigh Dickinson University.